From the Journals

Opioids still overprescribed for postop pain management


 

FROM THE JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Most patients use far less opioids than they are prescribed after hernia and other abdominal surgery, resulting in substantial waste and potential diversion, a prospective cohort study has found.

In an evaluation of 176 narcotic-naive patients who underwent surgery in a minimally invasive surgery service, the median opioid consumption over the 14-day postdischarge study period was 30 morphine milligram equivalents (MME) but the median prescription was 150 MME, reported Wen Hui Tan, MD, and her research team at Washington University, St. Louis. The report was published in the Journal of the American College of Surgeons.

Overall, 76.7% of patients reported being satisfied or very satisfied with their postoperative pain management. Some patients (n = 31, 17.6%) reported not filling their prescription or not taking any of their prescribed opioid pain medications at all.

Sixty-nine percent of the surgeries were laparoscopic. A variety of abdominal procedures were represented, including hiatal hernia repair, inguinal hernia repair, and cholecystectomy. The median age was 60 years. Of postoperative pain prescriptions, 67% were for hydrocodone-acetaminophen and most of the remainder were for oxycodone-acetaminophen or oxycodone alone. The median prescription was for the equivalent of 20 5-mg oxycodone pills, while the median consumption in the first 7 postoperative days was 3.7 pills. Only 4.5% of patients received a refill.

The findings are consistent with numerous studies of different types of operations showing that patients often don’t use all of the opioid medications they are prescribed for pain control after surgery.

“Now that opioid pain medications can no longer be refilled with a pharmacy via telephone, overprescription may also be partially driven by a desire to prevent future inconvenience and workload of office staff from patients requesting refills. However, the rising numbers of opioid-related unintentional deaths over the last decade point to the fact that overprescription has serious potential consequences,” the researchers wrote.

They reported having no potential conflicts of interest.

SOURCE: Tan et al. J Am Coll Surg 2018 May 7. doi: 10.1016/j.jamcollsurg.2018.04.032.

Recommended Reading

Constipation on opioids? Follow these three steps to ID the true cause
MDedge Internal Medicine
MDedge Daily News: How to handle opioid constipation
MDedge Internal Medicine
Marketing perks increased opioid prescriptions
MDedge Internal Medicine
TissueGene-C effects on knee OA seen at 3 years
MDedge Internal Medicine
Fremanezumab may be an effective episodic migraine treatment
MDedge Internal Medicine
Legalization of marijuana debate moving away from medical need
MDedge Internal Medicine
FDA approves Aimovig for migraine prevention
MDedge Internal Medicine
VIDEO: Pills alone not the answer for pain management
MDedge Internal Medicine
Disease burden higher in osteoarthritis than rheumatoid arthritis
MDedge Internal Medicine
FDA advisory panelists reject Buvaya for acute pain
MDedge Internal Medicine